An effective communication between the physician and the patient in an early intervention of hypertension and dyslipidemia [0.03%]
有效沟通在高血压和脂代谢紊乱早期干预中的作用
Barbora Nussbaumerová
Barbora Nussbaumerová
The article summarizes the cornestones of inicitating the pharmacotherapy of hypertension and dyslipidemia. The intervention of dyslipidemia should not be delayed after the intervention of hypertension. The compliance and the adhrence are f...
Kateřina Pokorná,Vladimír Kojecký
Kateřina Pokorná
A thymoma belongs to rather rare tumors, although it holds the first place among primary mediastinal tumors in adults. The biological characteristics of thymomas are considerably divergent. The tumors are usually asymptomatic at the beginin...
Chronic obstructive pulmonary disease: diagnosis and treatment of stable phase of disease; personalized treatment approach using phenotype features of the disease Summary of the 2020-2021 Czech Pneumological and Phthiseological Society position paper [0.03%]
慢性阻塞性肺疾病：诊断和治疗稳定期患者；采用表型特征的个性化治疗总结捷克肺炎与痨病学会2020-2021年立场文件要点
Kristián Brat,Jaromír Zatloukal,Kateřina Neumannová et al.
Kristián Brat et al.
Chronic obstructive pulmonary disease (COPD) is a heterogenous condition affecting hundreds of millions of people worldwide. COPD is a major health problem associated with significant morbidity and mortality. In this review, the authors pre...
Štefan Alušík
Štefan Alušík
Giant cell arteritis is the most common vasculitis in adults. The author presents the latest findings in diagnostics and treatment emphasising the growing importance of non-invasive examination methods where a biopsy of the temporal artery ...
Importance and efficiency of blood pressure control not only in type 2 diabetes patients [0.03%]
血压控制不仅在2型糖尿病患者中的重要性和有效性
Veronika Vejtasová,Jana Urbanová,Ludmila Brunerová et al.
Veronika Vejtasová et al.
Arterial hypertension is one of the most frequent comorbidities of patients with type 2 diabetes, the rates are approximately three times higher among diabetics than in general population. The presence of both diseases increases the cardiov...
Monitoring the dynamics of clinical and laboratory markers of chronic heart failure during 12 months of sacubitril/valsartan treatment [0.03%]
监测沙库必曲酯/缬沙坦治疗慢性心力衰竭患者12个月期间的临床和实验室标志物变化
Jana Čepelová,Marek Malý,Josef Daněk et al.
Jana Čepelová et al.
Aim: Treatment with sacubitril/valsartan (S/V) significantly improves cardiovascular morbidity, mortality, quality of life and prolongs the survival of chronic heart failure patients with reduced ejection fraction. The ai...
David Karásek
David Karásek
Dyslipidemia treatment represents a very dynamically growing segment of pharmacotherapy, including a production of biological agents. Nowadays, they are targeting at various proteins that are involved in the synthesis, transport, or metabol...
Treating inflammatory bowel diseases in the 21st century: individualized therapy and telemedicine [0.03%]
21世纪的炎症性肠病治疗：个体化疗法和远程医疗
Milan Lukáš
Milan Lukáš
Monitoring and therapy in patients with inflammatory bowel disease have been completely changed with regards of monitoring tolls, therapeutic aims and pursuance of therapeutic responses since of beginning this century. Uncomparable higher a...
Targeted and biological drugs in the treatment of inflammatory rheumatic diseases [0.03%]
抗炎性风湿病的靶向和生物制剂疗法
Karel Pavelka
Karel Pavelka
The aim of the review article is to provide an overview of biological and targeted drugs currently registered in the Czech Republic for the treatment of inflammatory rheumatic diseases. Specifically, the review deals with the treatment of r...
Vericiguat in patients with heart failure and reduced ejection fraction [0.03%]
射血分数降低的心力衰竭患者的维立西呱疗效试验
Jindřich Špinar,Lenka Špinarová,Jiří Vítovec
Jindřich Špinar
Background: The effect of vericiguat, a novel oral soluble guanylate cyclase stimulator, in patients with heart failure and reduced ejection fraction who had recently been hospitalized or had received intravenous diuretic...
Clinical Trial
Vnitrni lekarstvi. 2021 Summer;67(3):180-182. DOI: 2021